Article
DHHC7 palmitoylates KRAS4A and promotes mutant KRAS-driven pancreatic cancers
2026-04-02
Abstract excerpt
KRAS mutations underlie many human cancers. While inhibitors such as Sotorasib and Adagrasib targeting KRAS mutants have shown promise, additional strategies are required to address the broader spectrum of KRAS-driven cancers, particularly those displaying drug resistance. Thus, there is a need to better understand KRAS signaling and develop new therapeutic strategies. Here we show that KRAS4A is palmitoylated on...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6828aed2-9e01-5740-9f2e-a58c23c2470d
- DOI
- 10.64898/2026.03.31.715686
